Drug Type Biological products |
Synonyms TQB-2619 |
Target |
Action antagonists |
Mechanism CCR4 antagonists(C-C chemokine receptor type 4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Lymphocytic Leukemia | Preclinical | China | - | |
| T-Cell Lymphoma | Preclinical | China | - |





